TP53 and lip and oral cavity carcinoma: In a 2024 study, resveratrol induced feroptosis via the p53/SLC7A11 pathway in OSCC cell lines [191,229], and a March 2025 review supported its potent antiproliferative and antimetastatic actions in oral cancer models [235]; however, it does not hold drug approval [229].